← Back to Search

Behavioral Intervention

Time-Restricted Eating for Liver Cancer (TRE+HE Trial)

La Jolla, CA
N/A
Waitlist Available
Led By Nick Webster, PhD
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Child-Pugh A liver function
Overweight or obese (BMI 27-45 kg/m2)
Must not have
Type 1 diabetes or self-reported hypoglycemia or hypoglycemic events by CGM
Advanced HCC, progression, and/or associated comorbidities, metastatic disease, tumor in vein, or ascites
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-months
Awards & highlights
No Placebo-Only Group

Summary

"This trial will study the effects of a nutritional program on liver metabolism in patients with liver cancer. Participants will either follow a specific eating plan with restricted eating hours or be observed for six months. The main

See full description
Who is the study for?
This trial is for adults with liver cancer, specifically hepatocellular carcinoma, who may also be overweight or have fatty liver disease. Participants should be undergoing liver-directed therapies and willing to follow a nutritional program including time-restricted eating and diet changes.Check my eligibility
What is being tested?
The study tests if limiting eating to an 8-10 hour window daily combined with a healthy diet can improve liver metabolism in liver cancer patients. It includes dietary counseling and motivational support versus a control group under observation only.See study design
What are the potential side effects?
Since this intervention involves dietary changes rather than medication, side effects may include hunger outside of the eating window, potential nutrient deficiencies if not properly managed, and possible adjustment discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My liver functions well despite my condition.
 show original
Select...
My BMI is between 27 and 45.
 show original
Select...
My liver cancer is in an early to intermediate stage.
 show original
Select...
I can take care of myself but might not be able to do heavy physical work.
 show original

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have type 1 diabetes or have experienced low blood sugar.
 show original
Select...
My liver cancer is advanced, has spread, or caused other health issues.
 show original
Select...
I have severe liver disease with complications.
 show original
Select...
I do not have serious conditions like kidney disease or heart failure that would stop me from joining the trial.
 show original
Select...
I have lasting side effects from cancer treatment that are moderate or worse.
 show original

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Ability to recruit
Adherence to protocol
Safety from adverse events
+1 more
Secondary study objectives
Effect of intervention on Adiposity
Effect of intervention on Glucose levels
Effect of intervention on Quality of Life
+11 more
Other study objectives
Disease progression as a Tertiary/Exploratory outcome

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Intervention group will follow time-restricted consumption of a healthy diet.
Group II: ControlActive Control1 Intervention
Control observational arm.

Find a Location

Closest Location:University of California San Diego· La Jolla, CA· 1958 miles

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,212 Previous Clinical Trials
1,593,064 Total Patients Enrolled
54 Trials studying Obesity
7,526 Patients Enrolled for Obesity
Nick Webster, PhDPrincipal InvestigatorUniversoty of California San Diego
~33 spots leftby Dec 2026